Works matching DE "PROTHENA Corp. PLC"

Roche bets on alpha-synuclein for Parkinson's.

Published in:

Nature Biotechnology, 2014, v. 32, n. 3, p. 212, doi. 10.1038/nbt0314-212a

By:

• Sinha, Gunjan

Publication type:

Article